These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 16637685)

  • 1. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
    Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
    J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal kinetics of 3 lactoferricins against Staphylococcus aureus and Escherichia coli.
    Ulvatne H; Vorland LH
    Scand J Infect Dis; 2001; 33(7):507-11. PubMed ID: 11515760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of 15-residue lactoferricin derivatives.
    Strøm MB; Rekdal O; Svendsen JS
    J Pept Res; 2000 Nov; 56(5):265-74. PubMed ID: 11095180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli.
    van der Kraan MI; van Marle J; Nazmi K; Groenink J; van 't Hof W; Veerman EC; Bolscher JG; Nieuw Amerongen AV
    Peptides; 2005 Sep; 26(9):1537-42. PubMed ID: 16112390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of recombinant Arabian camel lactoferricin-related peptide in Pichia pastoris and its antimicrobial identification.
    Chahardooli M; Niazi A; Aram F; Sohrabi SM
    J Sci Food Agric; 2016 Jan; 96(2):569-75. PubMed ID: 25655077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin.
    Vorland LH; Ulvatne H; Andersen J; Haukland H; Rekdal O; Svendsen JS; Gutteberg TJ
    Scand J Infect Dis; 1998; 30(5):513-7. PubMed ID: 10066056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.
    Strøm MB; Rekdal O; Svendsen JS
    J Pept Sci; 2002 Jan; 8(1):36-43. PubMed ID: 11831560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-antibiotic effect of the antimicrobial peptide lactoferricin on Escherichia coli and Staphylococcus aureus.
    Haukland HH; Vorland LH
    J Antimicrob Chemother; 2001 Oct; 48(4):569-71. PubMed ID: 11581240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin.
    Nguyen LT; Schibli DJ; Vogel HJ
    J Pept Sci; 2005 Jul; 11(7):379-89. PubMed ID: 15635665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tryptophan in the antibacterial activity of a 15-residue bovine lactoferricin peptide.
    Haug BE; Svendsen JS
    J Pept Sci; 2001 Apr; 7(4):190-6. PubMed ID: 11354462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of a 2-arylsulphonylated tryptophan: the antibacterial activity of bovine lactoferricin peptides containing Trp(2-Pmc).
    Haug BE; Andersen J; Rekdal O; Svendsen JS
    J Pept Sci; 2002 Jul; 8(7):307-13. PubMed ID: 12148780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli.
    Flores-Villaseñor H; Canizalez-Román A; Reyes-Lopez M; Nazmi K; de la Garza M; Zazueta-Beltrán J; León-Sicairos N; Bolscher JG
    Biometals; 2010 Jun; 23(3):569-78. PubMed ID: 20195887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of antibiotic activity and synthesis of new pentadecapeptides based on lactoferricins.
    Lejon T; Stiberg T; Strøm MB; Svendsen JS
    J Pept Sci; 2004 Jun; 10(6):329-35. PubMed ID: 15214437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells.
    Yang N; Strøm MB; Mekonnen SM; Svendsen JS; Rekdal O
    J Pept Sci; 2004 Jan; 10(1):37-46. PubMed ID: 14959890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection.
    Yen CC; Shen CJ; Hsu WH; Chang YH; Lin HT; Chen HL; Chen CM
    Biometals; 2011 Aug; 24(4):585-94. PubMed ID: 21327478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.
    Arias M; McDonald LJ; Haney EF; Nazmi K; Bolscher JG; Vogel HJ
    Biometals; 2014 Oct; 27(5):935-48. PubMed ID: 24916114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
    Farnaud S; Patel A; Odell EW; Evans RW
    FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides.
    Liu Y; Han F; Xie Y; Wang Y
    Biometals; 2011 Dec; 24(6):1069-78. PubMed ID: 21607695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of milk proteins enhancing the antimicrobial activity of lactoferrin and lactoferricin.
    Murata M; Wakabayashi H; Yamauchi K; Abe F
    J Dairy Sci; 2013 Aug; 96(8):4891-8. PubMed ID: 23769363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-helical domain is essential for antimicrobial activity of high mobility group nucleosomal binding domain 2 (HMGN2).
    Feng Y; Huang N; Wu Q; Bao L; Wang BY
    Acta Pharmacol Sin; 2005 Sep; 26(9):1087-92. PubMed ID: 16115376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.